This CX Programme is subject to change.


Search for words

Abdominal Aortic Challenges - Wednesday, 17th April
Venue:   Upper Main Auditorium
Time: 08:00 - 18:00
Aortic Podium 1st session
Chairing:   Dittmar Böckler, President DGG, Heidelberg, Germany
Moderator:   Michel Makaroun, President SVS, Pittsburgh, United States
Abdominal Aortic
Time: 08:00 - 08:07
Podium 1st: ACT-guided heparinisation during non-cardiac arterial interventions: First results of the ACTION trial
Speaker:   Arno Wiersema, Amsterdam, Netherlands
Time: 08:07 - 08:14
Podium 1st: Potential EVAS cardiovascular mortality benefit through active sac management when compared to EVAR
Speaker:   Marc Schermerhorn, Boston, United States
Time: 08:14 - 08:21
Podium 1st: Exercise for abdominal aortic aneurysm patients: Early results from the AAA Get Fit Trial
Speaker:   Charles McCollum, Manchester, United Kingdom
Time: 08:21 - 08:31
Audience participation and discussion
Time: 08:31 - 08:38
Podium 1st: Early results and implication of internal iliac preservation on quality of life
Speaker:   Fabio Verzini, Turin, Italy
Time: 08:38 - 08:45
Podium 1st: EVAR plus endoanchors in the treatment of short proximal necks is a viable option: Two-year clinical results
Speaker:   Frank Arko, Charlotte, United States
Time: 08:45 - 08:55
Audience participation, discussion and polling
Time: 08:55 - 09:02
Podium 1st: FRONTIER IV data with a large bore closure device
Speaker:   Daniela Branzan, Leipzig, Germany
Time: 09:02 - 09:09
Podium 1st: New developments in fusion imaging - artificial intelligence that deforms anatomy to maintain accuracy
Speaker:   Bijan Modarai, London, United Kingdom
Time: 09:09 - 09:16
Podium 1st: The impact of polymer sealing on neck-related adverse events: Five-year results from ENCORE
Speaker:   Hence J M Verhagen, Rotterdam, Netherlands
Time: 09:16 - 09:26
Audience participation, discussion and polling
 
Thoracic Aortic
Chairing:   Tilo Kölbel, Hamburg, Germany
Moderator:   Frank Vermassen, Ghent, Belgium
Time: 09:26 - 09:33
Podium 1st: Thirty-day clinical results of global cohort with new thoracic aortic endograft
Speaker:   Fabio Verzini, Turin, Italy
Time: 09:33 - 09:40
Podium 1st: Use of inner branches in complex aneurysms - early results of the Iberian Study
Speaker:   Jorge Fernández Noya, Santiago Compostela, Spain
Time: 09:40 - 09:47
Podium 1st: T-branch registry: Results of an off-the-shelf endograft for thoracoabdominal aneurysms
Speaker:   Martin Austermann, Münster, Germany
Time: 09:47 - 10:00
Audience participation and discussion
 
Coffee and visit to hands-on workshops
Time: 10:00 - 10:30
Coffee Symposium: Expanding aortic treatment indications
Chairing:   Robert Rhee, New York, United States
Time: 10:03 - 10:09
The importance of precise placement, optimal seal and conformability in treating challenging thoracic aortic cases
Speaker:   Dittmar Böckler, President DGG, Heidelberg, Germany
Time: 10:09 - 10:15
An innovative solution to expand on-label aortic treatment
Speaker:   Salma El Batti, Paris, France
Time: 10:15 - 10:21
A treatment algorithm for EVAR: Anatomical considerations, disease state and proper device selection
Speaker:   Michel Reijnen, Arnhem, Netherlands
Time: 10:21 - 10:28
Audience participation and discussion
 
Edited case
Chairing:   Robert Rhee, New York, United States
Time: 10:30 - 11:00
Edited case: Expanding EVAR indications with a next-generation AAA endograft conforming to 90-degree neck angulations and seal in short 10mm necks
Speaker:   Jorge Fernández Noya, Santiago Compostela, Spain
 
Durability of endovascular aneurysm repair and the NICE guidelines
Time: 11:00 - 12:30
Chairing:   Roger Greenhalgh, London, United Kingdom
Moderators:   Tilo Kölbel, Hamburg, Germany
Maarit Venermo, Helsinki, Finland
Live case with virtual reality from Paris: Low-profile abdominal aortic stent graft (30min)
Operator:   Stephan Haulon, Le Plessis Robinson, France
NICE aortic guidelines - the latest (5min)
Speaker:   Andrew Bradbury, Birmingham, United Kingdom
EVAR - a standard of care (5min)
Speaker:   Tara Mastracci, London, United Kingdom
NICE AAA draft guidelines: a viewpoint from Wales (5min)
Speaker:   Louis Fligelstone, Swansea, United Kingdom
Sac reduction as primary indicator of success after EVAR (5min)
Speaker:   Vincent Riambau, Barcelona, Spain
Audience participation, discussion and polling (10min)
Estimation of Long-Term Aortic Risk (LEAR) Model to improve EVAR surveillance (5min)
Speaker:   Peter Holt, London, United Kingdom
EVAR durability and endoleaks in 2019 the US perspective (5min)
Speaker:   Ronald Dalman, Vice-President SVS, Stanford, United States
Indications for reinterventions after EVAR (5min)
Speaker:   Lars Lönn, Copenhagen, Denmark
Audience participation, discussion and polling (10min)
Optimising surveillance and reintervention strategy following elective EVAR (25min)
Speakers:   Fiona Rohlffs, Hamburg, Germany
Maarit Venermo, Helsinki, Finland
Lois Kim, Cambridge, United Kingdom
David Epstein, Granada, Spain
Roger Greenhalgh, London, United Kingdom
Audience participation, discussion and polling (10min)
 
Lunch and visit to hands-on workshops
Time: 12:30 - 13:30
Lunch Symposium: Over 15 years of experience with a reliable, proven, trusted balloon-expandable covered stent
Chairing:   Jean-Paul de Vries, Groningen, Netherlands
Time: 12:32 - 12:40
Reliable performance and proven long-term results of a balloon-expandable covered stent
Speaker:   Eric Verhoeven, Nuremberg, Germany
Time: 12:40 - 12:48
How does the leading balloon-expandable covered stent make a difference?
Speaker:   Tilo Kölbel, Hamburg, Germany
Time: 12:48 - 12:56
Audience participation and discussion
 
Global recruitment into the Vascular Specialty
Chairing:   Trevor Cleveland, President BSIR, Sheffield, United Kingdom
Moderator:   Ronald Dalman, Vice-President SVS, Stanford, United States
Time: 13:30 - 13:35
The sooner the better - How can medical students be attracted to (vascular) surgery
Speaker:   Hans-Henning Eckstein, Munich, Germany
Time: 13:35 - 13:40
Recruitment into the venous specialty in Wales
Speaker:   Louis Fligelstone, Swansea, United Kingdom
Time: 13:40 - 13:45
Audience participation and discussion
Time: 13:45 - 13:50
The European perspective
Speaker:   Henrik Sillesen, President ESVS, Copenhagen, Denmark
Time: 13:50 - 13:55
The US perspective
Speaker:   Michel Makaroun, President SVS, Pittsburgh, United States
Time: 13:55 - 14:00
Audience participation and discussion
Time: 14:00 - 14:05
The Latin American perspective
Speaker:   Alberto Muñoz, President WFVS, Bogotá, Colombia
Time: 14:05 - 14:10
The EBVS perspective
Speaker:   Armando Mansilha, President EBVS, Porto, Portugal
Time: 14:10 - 14:15
The UK perspective
Speaker:   Sophie Renton, Secretary General VSGBI, London, United Kingdom
Time: 14:15 - 14:20
Audience participation, discussion and polling
 
Volume and outcomes
Chairing:   Janet Powell, London, United Kingdom
Moderator:   Eric Verhoeven, Nuremberg, Germany
Time: 14:20 - 14:27
Impact of the patient risk on the volume-outcome effect for AAA surgery
Speaker:   Matthias Trenner, Munich, Germany
Time: 14:27 - 14:34
Volume outcome in AAA repair
Speaker:   Marc Schermerhorn, Boston, United States
Time: 14:34 - 14:41
Systematic review of volume-outcome relationship in open and endo AAA repair
Speaker:   Dittmar Böckler, President DGG, Heidelberg, Germany
Time: 14:41 - 14:48
Regionalisation of ruptured abdominal aortic aneurysm is safe and cost-effective
Speaker:   Clement Darling III, Albany, United States
Time: 14:48 - 15:00
Audience participation, discussion and polling
 
Challenging aortic issues
Chairing:   Frans Moll, CX Advisory Board, Utrecht, Netherlands
Moderator:   Ronald Dalman, Vice-President SVS, Stanford, United States
Time: 15:00 - 15:07
Innovation in 3D navigation using light instead of fluoroscopy: First-in-human trial and case review
Speaker:   Joost van Herwaarden, Utrecht, Netherlands
Time: 15:07 - 15:14
Risk prediction model of in-hospital mortality following elective abdominal aortic aneurysm repair
Speaker:   Thomas Schmitz-Rixen, Immediate Past President DGG, Frankfurt, Germany
Time: 15:14 - 15:21
Late secondary rupture after EVAR: 10 years' experience
Speaker:   Vincenzo Brizzi, Bordeaux, France
Time: 15:21 - 15:30
Audience participation, discussion and polling
 
Tea and visit to hands-on workshops
Time: 15:30 - 16:00
Tea Symposium: From infrarenal AAA to complex TAAA repair: Endovascular outcomes and future hybrid innvations
Chairing:   David Murray, Altrincham, United Kingdom
Time: 15:32 - 15:40
Early results from a registry of endovascular repair of abdominal aortic aneurysm
Speaker:   David Murray, Altrincham, United Kingdom
Time: 15:40 - 15:48
Fenestrated endovascular repair of abdominal aortic aneurysm
Speaker:   Randy Moore, Calgary, Canada
Time: 15:48 - 15:56
Future innovations to address complex TAAA repair
Speaker:   Sebastian Debus, Hamburg, Germany
 
Challenging aortic issues (continued)
Chairing:   Tara Mastracci, London, United Kingdom
Moderator:   Tilo Kölbel, Hamburg, Germany
Time: 16:05 - 16:10
CX Debate: Hostile necks should be treated with standard EVAR devices

For the motion
Time: 16:05 - 16:10
Hence J M Verhagen, President elect Dutch Vascular Society, Rotterdam, Netherlands

Against the motion
Time: 16:05 - 16:10
Giovanni Torsello, Münster, Germany

Time: 16:10 - 16:15
Audience participation, discussion and polling
Time: 16:15 - 16:22
On-label treatment of short and angulated necks with a new conformable EVAR device
Speaker:   Robert Rhee, New York, United States
Time: 16:22 - 16:29
Gender disparities in the outcome of aortic repair
Speaker:   Janet Powell, London, United Kingdom
Time: 16:29 - 16:36
Impact of female gender in the outcomes of severe aortoiliac obstructive disease
Speaker:   Michele Antonello, Padua, Italy
Time: 16:36 - 16:43
Patients with familial abdominal aortic aneurysm have more complications and a higher 30-day mortality after EVAR
Speaker:   Hence J M Verhagen, Rotterdam, Netherlands
Time: 16:43 - 16:50
The changing face of aortic disease - the implications of an ageing population
Speaker:   Dominic Howard, Oxford, United Kingdom
Time: 16:50 - 17:05
Audience participation and discussion
Time: 17:05 - 17:15
CX Debate: The vast majority of failed EVARs can be treated endovascularly

For the motion
Time: 17:05 - 17:10
Jean-Pierre Becquemin, Champigny-sur-Marne, France

Against the motion
Time: 17:10 - 17:15
Michel Makaroun, President SVS, Pittsburgh, United States

Time: 17:15 - 17:20
Audience participation, discussion and polling
Time: 17:20 - 17:27
Embolisation of renal artery aneurysms
Speaker:   Joo-Young Chun, London, United Kingdom
Time: 17:27 - 17:34
Management of visceral artery aneurysms
Speaker:   Lindsay Machan, Vancouver, Canada
Time: 17:34 - 17:41
Sac embolisation during EVAR - results from a prospective randomised study
Speaker:   Dominique Fabre, Le Plessis Robinson, France
Time: 17:41 - 17:48
Endoleak diagnosis and clinical outcomes of embolisation with a liquid embolic agent
Speaker:   Frank Arko, Charlotte, United States
Time: 17:48 - 18:00
Audience participation and discussion